- $3.12m
- $1.24m
- $9.29m
Annual balance sheet for iSpecimen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.696 | 27.7 | 15.3 | 5.01 | 1.88 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.36 | 4.88 | 4.07 | 2.94 | 1.44 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.47 | 32.9 | 19.7 | 8.24 | 3.59 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.076 | 0.033 | 0.411 | 0.322 | 0.422 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 6.21 | 35.7 | 24.6 | 15.8 | 9.35 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22.1 | 2.51 | 4.28 | 6.05 | 5.77 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 22.3 | 5.93 | 4.31 | 6.08 | 6.04 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -16.1 | 29.8 | 20.3 | 9.74 | 3.31 |
Total Liabilities & Shareholders' Equity | 6.21 | 35.7 | 24.6 | 15.8 | 9.35 |
Total Common Shares Outstanding |